NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Mar 01, 2022 $2.01 $2.03 $1.93 $1.95 256 900
Feb 28, 2022 $1.95 $2.03 $1.95 $1.99 168 800
Feb 25, 2022 $1.98 $2.04 $1.93 $1.95 152 100
Feb 24, 2022 $1.80 $1.98 $1.75 $1.95 688 900
Feb 23, 2022 $2.04 $2.07 $1.93 $1.93 237 300
Feb 22, 2022 $2.10 $2.11 $1.99 $2.03 437 300
Feb 18, 2022 $2.22 $2.23 $2.14 $2.16 244 600
Feb 17, 2022 $2.21 $2.28 $2.19 $2.23 259 500
Feb 16, 2022 $2.19 $2.31 $2.18 $2.21 281 400
Feb 15, 2022 $2.47 $2.47 $2.15 $2.21 920 200
Feb 14, 2022 $2.31 $2.50 $2.30 $2.45 384 200
Feb 11, 2022 $2.66 $2.68 $2.43 $2.47 851 900
Feb 10, 2022 $2.40 $2.83 $2.31 $2.71 1 470 200
Feb 09, 2022 $2.37 $2.64 $2.36 $2.52 1 067 300
Feb 08, 2022 $2.31 $2.36 $2.12 $2.36 740 200
Feb 07, 2022 $2.15 $2.25 $2.14 $2.19 381 900
Feb 04, 2022 $2.03 $2.12 $1.97 $2.11 343 400
Feb 03, 2022 $1.98 $2.16 $1.95 $2.01 758 700
Feb 02, 2022 $2.09 $2.09 $1.93 $2.01 382 200
Feb 01, 2022 $1.96 $2.13 $1.90 $2.07 560 000
Jan 31, 2022 $1.87 $1.96 $1.81 $1.95 639 800
Jan 28, 2022 $1.54 $1.96 $1.50 $1.90 1 473 100
Jan 27, 2022 $1.66 $1.67 $1.55 $1.57 372 200
Jan 26, 2022 $1.70 $1.76 $1.65 $1.66 490 800
Jan 25, 2022 $1.59 $1.71 $1.57 $1.69 302 800
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT